Central Nervous System Lymphoma
📧 Sign up to get email alerts when something new happens for Central Nervous System Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma [Phase 2]
The Phase 2 trial of antineoplaston therapy for primary central nervous system lymphoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma [Phase 2]
A Phase 2 trial evaluating the combination of methotrexate and thiotepa for newly diagnosed primary central nervous system lymphoma has comp…
-
CLINICAL_TRIALS research · 2013-04-17Clinical Trial Update: Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma [Phase 2]
This document reports a Phase 2 clinical trial update for temsirolimus in recurrent primary central nervous system lymphoma.
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma [Phase 2]
A Phase 2 trial evaluating temozolomide, nedaplatin, vincristine, and radiotherapy as first-line treatment for newly diagnosed primary centr…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma [Phase 1]
A Phase 1 trial evaluating genetic testing-guided irinotecan therapy in patients with solid tumors or lymphoma; the study status is complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma [NA]
Clinical trial evaluating Rituximab in combination with Yttrium-90 ibritumomab tiuxetan for recurrent primary central nervous system lymphom…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma [Phase 2]
Memorial Sloan Kettering reported a Phase 2 trial evaluating combination chemotherapy followed by peripheral stem cell transplantation for n…
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma [Phase 2]
This update reports results from a Phase II trial evaluating sequential chemotherapy followed by radiotherapy for AIDS-related primary centr…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma [Phase 2]
Phase 2 clinical trial results for combining chemotherapy with radiation therapy in patients with primary central nervous system lymphoma.
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study [Phase 2]
A Phase 2 study assessing high-dose methotrexate induction followed by methotrexate- and cytarabine-based consolidation for newly diagnosed …
-
CLINICAL_TRIALS withdrawal · 2012-05-18Clinical Trial Update: Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL [EARLY_Phase 1]
A Phase 1 pilot trial evaluating motexafin gadolinium with high-dose methotrexate-based chemoimmunotherapy and radiation for newly diagnosed…
-
CLINICAL_TRIALS withdrawal · 2012-03-20Clinical Trial Update: Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma [Phase 2]
A Phase 2 trial evaluating chemotherapy with filgrastim and radiation therapy for primary central nervous system lymphoma has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: Cognitive Functioning and Quality of Life in CNS Lymphoma
A completed clinical trial update reports on cognitive functioning and quality of life outcomes in patients with central nervous system lymp…
-
CLINICAL_TRIALS withdrawal · 2011-09-20Clinical Trial Update: Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating pemetrexed for recurrent or progressive primary central nervous system lymphoma has been withdrawn. The …
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma [Phase 2]
This update reports a phase 2 salvage therapy trial of idarubicin for relapsing primary central nervous system lymphoma, sponsored by IELSG,…
-
CLINICAL_TRIALS trial_result · 2009-12-24Clinical Trial Update: Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL) [Phase 4]
A Phase 4 trial evaluating whole brain irradiation for primary central nervous system lymphoma has completed.
-
CLINICAL_TRIALS research · 2009-11-17Clinical Trial Update: Freiburg ZNS-NHL Study [Phase 2]
A Phase 2 clinical trial at University Hospital Freiburg is investigating primary central nervous system lymphoma, with the study status cur…
-
CLINICAL_TRIALS research · 2009-10-05Clinical Trial Update: Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating methotrexate-based chemo-immunotherapy followed by maintenance therapy in patients over 65 with primary …
-
CLINICAL_TRIALS research · 2007-04-04Clinical Trial Update: a Phase II Study in Primary Central Nervous System Lymphoma [Phase 2]
This clinical trial update describes a Phase II study for primary central nervous system lymphoma, with the current status listed as UNKNOWN…